Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents

被引：8
|
作者：
Rizzo, Renata [1 ]
Martino, Davide [2 ,3 ]
机构：
[1] Univ Catania, Neuropsichiatria Infantile, Dipartimento Sci Med & Pediat, I-95123 Catania, Italy
[2] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England
[3] Queen Elizabeth Hosp, Lewisham & Greenwich NHS Trust, London, England
来源：
EXPERT REVIEW OF NEUROTHERAPEUTICS | 2015年 / 15卷 / 04期
关键词：
alpha(2)-adrenoreceptor agonist; attention deficit hyperactivity disorder; guanfacine extended-release; guanfacine immediate-release; treatment; EXTENDED-RELEASE; DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; OPEN-LABEL; LONG-TERM; PHASE-I; ADHD; PHARMACOKINETICS; PSYCHOSTIMULANTS; NEUROBIOLOGY;
D O I：
10.1586/14737175.2015.1028370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Guanfacine is an (2A)-adrenoreceptor agonist currently indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This article reviews the chemistry, pharmacodynamics and pharmacokinetics of guanfacine, as well as the clinical trial literature on guanfacine for the treatment of ADHD in children and adolescents, mainly focusing on the use of guanfacine extended-release (GXR). Six already published prospective randomized controlled trials (RCTs) and one unpublished RCT study were identified for GXR in the treatment of ADHD. All RCTs trials showed superiority over placebo on the primary outcome measure. Guanfacine, especially XR, seems to be an effective and safe treatment option for ADHD in children and adolescents.
引用
收藏
页码：347 / 354
页数：8
相关论文
共 50 条
  • [1] Guanfacine Extended Release: A Novel Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Faraone, Stephen V.
    McBurnett, Keith
    Sallee, Floyd R.
    Steeber, Jennifer
    Lopez, Frank A.
    CLINICAL THERAPEUTICS, 2013, 35 (11) : 1778 - 1793
  • [2] Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Connor, Daniel F.
    Arnsten, Amy F. T.
    Pearson, Geraldine S.
    Greco, Gabriella F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1601 - 1610
  • [3] Cardiological Findings in Children and Adolescents Before and After Guanfacine Treatment for Attention Deficit and Hyperactivity Disorder
    Yukcu, Bekir
    Onal, Bedia Sultan
    Osmanli, Cansu Cobanoglu
    Tonkaz, Gulsum Yitik
    Sahin, Berkan
    CHILDREN-BASEL, 2025, 12 (03):
  • [4] GUANFACINE EXTENDED RELEASE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS
    Connor, D. F.
    Rubin, J.
    DRUGS OF TODAY, 2010, 46 (05) : 299 - 314
  • [5] Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
    Martinez-Raga, Jose
    Knecht, Carlos
    de Alvaro, Raquel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1359 - 1370
  • [6] Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder
    Bukstein, Oscar Gary
    Head, Jared
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2207 - 2213
  • [7] Guanfacine Extended Release as Adjunctive Therapy to Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    ADVANCES IN THERAPY, 2012, 29 (05) : 385 - 400
  • [8] Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
    Mattos, Paulo
    REVISTA DE PSIQUIATRIA CLINICA, 2014, 41 (02): : 34 - 39
  • [9] Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
    Hammerness, Paul
    McCarthy, Katherine
    Mancuso, Elizabeth
    Gendron, Cassandra
    Geller, Daniel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 215 - 226
  • [10] Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
    Huss, Michael
    Sikirica, Vanja
    Hervas, Amaia
    Newcorn, Jeffrey H.
    Harpin, Valerie
    Robertson, Brigitte
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1085 - 1101
12345